Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol as an Adjunctive to Prolonged Exposure for PTSD
NCT03518801Phase 2Completed
- Sponsor
- VA Office of Research & Development
- Start
- Oct 2019
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Oct 2019; status: completed.
02
Drugs
cannabidiol
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03518801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03518801.